Tylenol maker Kenvue blasts Trump administration's autism claim
Briefly

Tylenol maker Kenvue blasts Trump administration's autism claim
""acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy""
""rigorous research, endorsed by leading medical professionals and global health regulators, confirms there is no credible evidence linking acetaminophen to autism.""
""We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers.""
President Trump is scheduled to appear with Health Secretary Robert F. Kennedy Jr. and CMS administrator Mehmet Oz at a White House event to draw a connection between autism and acetaminophen use during pregnancy. Kennedy has promoted debunked theories about autism and indicated conclusions from a government report would be revealed this month. Kenvue, maker of Tylenol, stated that acetaminophen is the safest pain reliever for pregnant women and that rigorous research finds no credible evidence linking it to autism. Kenvue shares fell sharply amid the controversy. Kenvue was spun off from J&J in 2023 and sells former J&J consumer health brands.
Read at Axios
Unable to calculate read time
[
|
]